Bioventus Inc. (BVS) stock
BVSNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 26, 2026Last filing: 10-Q on Nov 2, 2026Score 14/3033% below fair value
$10.86−0.13 (-1.18%)
Close on Nov 12, 2026Market cap $913.24MP/E 13.6Yield –
Bioventus enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Bioventus's enterprise value was $1.03B on Nov 11, 2026, against $831.76M a year earlier. Over the last 5 years it ranged from $535.22M to $1.25B, with a median of $821.67M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $1.03B | +25.0% |
| 2025 | Dec 31, 2025 | $821.67M | -21.8% |
| 2024 | Dec 31, 2024 | $1.05B | +40.9% |
| 2023 | Dec 29, 2023 | $745.34M | +28.0% |
| 2022 | Dec 30, 2022 | $582.42M | – |
See a number that looks wrong?